BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12658952)

  • 1. Researchers sound the alarm on risks associated with metabolic syndrome.
    Dis Manag Advis; 2003 Feb; 9(2):25, 27, 17. PubMed ID: 12658952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurses can lead the charge in tackling metabolic syndrome.
    Dis Manag Advis; 2005 Jan; 11(1):10-1, 1. PubMed ID: 15766058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome--early action to decrease risks for cardiovascular disease.
    Fritschi C; Richlin D
    AAOHN J; 2004 Aug; 52(8):320-2. PubMed ID: 15357369
    [No Abstract]   [Full Text] [Related]  

  • 5. The metabolic syndrome and cardiovascular risk: implications for clinical practice.
    Eddy DM; Schlessinger L; Heikes K
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S5-10. PubMed ID: 18469838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome.
    Reaven P
    J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome & obesity: co-epidemics could overwhelm home health care.
    Pearce LC
    Caring; 2003 Jun; 22(6):24-8, 30, 32-3; quiz 34-6. PubMed ID: 12905569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on lifestyle change and the metabolic syndrome.
    Stone NJ
    Endocrinol Metab Clin North Am; 2004 Sep; 33(3):493-508, v-vi. PubMed ID: 15262293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting vascular risk in patients with metabolic syndrome but without diabetes.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Didangelos TP; Peletidou A; Kleta D; Karagiannis A; Kakafika AI; Tziomalos K; Elisaf M
    Metabolism; 2005 Aug; 54(8):1065-74. PubMed ID: 16092057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges associated with metabolic syndrome.
    Spinler SA
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
    Klausen KP; Parving HH; Scharling H; Jensen JS
    J Intern Med; 2007 Oct; 262(4):470-8. PubMed ID: 17875184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
    Battista M; Murray RD; Daniels SR
    Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality.
    Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY
    Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A complex web of risks for metabolic syndrome: race/ethnicity, economics, and gender.
    Salsberry PJ; Corwin E; Reagan PB
    Am J Prev Med; 2007 Aug; 33(2):114-20. PubMed ID: 17673098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and cardiovascular disease.
    Citrome L
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):84-93. PubMed ID: 16280341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and metabolic risk factors: how can we improve outcomes in the high-risk patient?
    Grundy SM
    Am J Med; 2007 Sep; 120(9 Suppl 1):S3-8; discussion S9. PubMed ID: 17720359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.